Tailored drugs aim to stop pancreatic cancer's return after surgery
NCT ID NCT06228599
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving patients drugs that match their tumor's unique molecular profile can prevent pancreatic cancer from coming back after surgery. It includes 40 adults whose cancer was removed but who are at high risk of recurrence. Researchers will track how long patients stay cancer-free and monitor side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Froedtert Hospital & the Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can High-Dose vitamin c boost Chemo's punch against pancreatic cancer?
- Can High-Dose vitamin c boost chemo against pancreatic cancer?
- Could a simple blood test catch pancreatic cancer before It's too late?
- Could an ALS drug clear the fog of chemo brain?
- Scientists hunt for clues to prevent a common complication after pancreatic cancer surgery
- Music may soothe pain at the genetic level after cancer surgery